← Stock Screener

VRTX — Vertex Pharmaceuticals Incorporated

Healthcare · Biotechnology · NASDAQ

$474.67

Market Cap: $120.5B

Key Fundamentals

P/E Ratio
30.5
P/B Ratio
6.2
Return on Equity
23.9%
Net Profit Margin
32.3%
Revenue Growth
9.6%
Dividend Yield
0.0%
Debt / Equity
0.1
EPS (TTM)
$15.56
Piotroski F-Score
8/9
Beta
0.31

About Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated (ticker: VRTX, listed on NASDAQ) is a company in the Healthcare · Biotechnology sector with a market capitalization of $120.5B.

This page shows publicly available fundamental data for VRTX sourced from Valory's database of 36,000+ US stocks. For deeper analysis — including Valory Formula projected returns, historical financials, and analyst consensus — create a free account.

Sign Up Free for Full Analysis   Browse All US Stocks

Data is updated regularly during US market hours. Fundamental data is sourced from public filings and market data providers. This page is for informational purposes only and does not constitute investment advice.